Adjuvant chemotherapy following complete resection of soft tissue sarcoma in adults: a clinical practice guideline

By Figueredo Alvaro   Bramwell Vivien H.C.   Bell Robert   Davis Aileen M.   Charette Manya L.  

Sarcoma, Vol. 6, Iss. 1, 2002-03 ,pp. : 5-18

Informa Healthcare

Access to resources Recommend Favorite

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I.   Radford J.A.   Harris M.   Blay J.-Y.   van Hoesel Q.   le Cesne A.   van Oosterom A.T.   Clemons M.J.   Kamby C.   Hermans C.   Whittaker J.   Donato di Paola E.   Verweij J.   Nielsen S.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite

A phase II study of docetaxel in chemotherapy-naive patients with recurrent or metastatic adult soft tissue sarcoma

By Bramwell Vivien   Blackstein Martin   Belanger Karl   Verma Shail   Beare Sandra   Eisenhauer Elizabeth  

Sarcoma, Vol. 2, Iss. 1, 1998-03 ,pp. : 29-33

Informa Healthcare

Access to resources Recommend Favorite

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy

By Blay J.-Y.   van Glabbeke M.   Verweij J.   van Oosterom A.T.   Le Cesne A.   Oosterhuis J.W.   Judson I.   Nielsen O.S.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 64-69

Elsevier

Access to resources Recommend Favorite

Gemcitabine in bone sarcoma resistant to doxorubicin-based chemotherapy

By Merimsky Ofer   Meller Isaac   Kollender Yehuda   Issakov Josephine   Flusser Gideon   Inbar Moshe  

Sarcoma, Vol. 4, Iss. 1-2, 2000-03 ,pp. : 7-10

Informa Healthcare

Access to resources Recommend Favorite